Filing Flows › Picard Medical (PMI) › R&D spending
Picard Medical (PMI) R&D spending by quarter
Picard Medical's R&D spending was $1.4M in Q2 2026 (second quarter 2026), -27% from Q1 2026. Over the last 5 quarters it ranged from $547K (Q4 2025) to $1.9M (Q1 2026).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.4M | -27% | +85% |
| Q1 2026 | $1.9M | +246% | — |
| Q4 2025 | $547K | -42% | — |
| Q3 2025 | $951K | +28% | — |
| Q2 2025 | $743K | — | — |
Q2 2026 at a glance
Picard Medical, Q2 2026: revenue $3.0M (+39% year over year), operating margin -156.7%, net loss $5.7M, operating cash flow −$1.4M. The chart follows the revenue to costs, profit and cash.
Questions
What is Picard Medical's R&D spending?
Picard Medical's R&D spending was $1.4M in Q2 2026 (second quarter 2026), -27% from Q1 2026.
How has Picard Medical's R&D spending changed?
Over the last 5 quarters it ranged from $547K (Q4 2025) to $1.9M (Q1 2026).